Literature DB >> 22415699

On the choice of parameterisation and priors for the Bayesian analyses of Mendelian randomisation studies.

E M Jones1, J R Thompson, V Didelez, N A Sheehan.   

Abstract

Mendelian randomisation is a form of instrumental variable analysis that estimates the causal effect of an intermediate phenotype or exposure on an outcome or disease in the presence of unobserved confounding, using a genetic variant as the instrument. A Bayesian approach allows current knowledge to be incorporated into the analysis in the form of informative prior distributions, and the unobserved confounder can be modelled explicitly. We consider Bayesian methods for Mendelian randomisation in the case where all relationships are linear and there are no interactions. A 'full' model in which the unobserved confounder is included explicitly is not completely identifiable, although the causal parameter can be estimated. We compare inferences from this general but non-identified model with a reduced parameter model that is identifiable. We show that, theoretically, additional information about the causal parameter can be obtained by using the non-identifiable full model, rather than the identifiable reduced model, but that this is advantageous only when realistically informative priors are used and when the instrument is weak or the sample size is small. Furthermore, we consider the impact of using 'vague' versus 'informative' priors.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22415699     DOI: 10.1002/sim.4499

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  8 in total

Review 1.  Statistical methods for Mendelian randomization in genome-wide association studies: A review.

Authors:  Frederick J Boehm; Xiang Zhou
Journal:  Comput Struct Biotechnol J       Date:  2022-05-14       Impact factor: 6.155

2.  Bayesian mendelian randomization with study heterogeneity and data partitioning for large studies.

Authors:  Linyi Zou; Hui Guo; Carlo Berzuini
Journal:  BMC Med Res Methodol       Date:  2022-06-03       Impact factor: 4.612

3.  Bayesian regression discontinuity designs: incorporating clinical knowledge in the causal analysis of primary care data.

Authors:  Sara Geneletti; Aidan G O'Keeffe; Linda D Sharples; Sylvia Richardson; Gianluca Baio
Journal:  Stat Med       Date:  2015-03-24       Impact factor: 2.373

4.  Inferring the direction of a causal link and estimating its effect via a Bayesian Mendelian randomization approach.

Authors:  Ioan Gabriel Bucur; Tom Claassen; Tom Heskes
Journal:  Stat Methods Med Res       Date:  2019-05-30       Impact factor: 3.021

5.  Epidemiology, genetic epidemiology and Mendelian randomisation: more need than ever to attend to detail.

Authors:  Nuala A Sheehan; Vanessa Didelez
Journal:  Hum Genet       Date:  2019-05-27       Impact factor: 4.132

6.  Overlapping-sample Mendelian randomisation with multiple exposures: a Bayesian approach.

Authors:  Linyi Zou; Hui Guo; Carlo Berzuini
Journal:  BMC Med Res Methodol       Date:  2020-12-07       Impact factor: 4.615

7.  A Bayesian approach to Mendelian randomization with multiple pleiotropic variants.

Authors:  Carlo Berzuini; Hui Guo; Stephen Burgess; Luisa Bernardinelli
Journal:  Biostatistics       Date:  2020-01-01       Impact factor: 5.899

Review 8.  A review of instrumental variable estimators for Mendelian randomization.

Authors:  Stephen Burgess; Dylan S Small; Simon G Thompson
Journal:  Stat Methods Med Res       Date:  2015-08-17       Impact factor: 3.021

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.